Product Information

LISDEXAMFETAMINE 60 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $2.4823 per EA under NDC 31722035501. Its NADAC has been published 98 times since Jan 8, 2025.

FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 60 MG CAPSULE

Lisdexamfetamine dimesylate
$2.4823per EA
DEA Schedule CII

Strength

60 mg/1

NDC

31722035501

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA217442

FDA Approved

8/25/2023

TE Code

AB

On Market Since

9/9/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 60 MG CAPSULE has been published 98 times since Jan 8, 2025, and over the history we have for it it has declined 56.8%. The table below summarizes its recorded NADAC range and movement.

Current price$2.4823 per EA
All-time high$5.7397 (Jan 15, 2025)
All-time low$2.4823 (Nov 18, 2026)
52-week high$3.2668
52-week low$2.4823
Median price$3.2201
Average price$3.6292
Largest weekly change-12.6% (Jul 23, 2025)
Weeks tracked98
Tracking sinceJan 8, 2025

Price History

1W

-4.7%

1M

-7.1%

3M

-11.8%

6M

-16.4%

1Y

-25.8%

3Y

N/A

5Y

N/A

All

-56.8%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 60 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 60 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $2.4823 per EA (NDC 31722035501), effective Nov 18, 2026.

How has the price of LISDEXAMFETAMINE 60 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 60 MG CAPSULE has declined 56.8%. It has been tracked across 98 weekly CMS publications since Jan 8, 2025.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 60 MG CAPSULE?

Since Jan 8, 2025, the NADAC for LISDEXAMFETAMINE 60 MG CAPSULE has ranged from a low of $2.4823 (Nov 18, 2026) to a high of $5.7397 (Jan 15, 2025), with a median of $3.2201 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 60 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 60 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 60 MG CAPSULE?

LISDEXAMFETAMINE 60 MG CAPSULE (NDC 31722035501) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.